癒着防止用の断片化重合体ヒドロゲルおよびそれらの調製

Japanese Patent JP4843079

B2

Molecular cross-linked gels comprise a variety of biologic and non-biologic polymers, such as proteins, polysaccharides, and synthetic polymers. Such molecular gels may be applied to target sites in a patient's body by extruding the gel through an orifice at the target site. Alternatively, the gels may be mechanically disrupted and used in implantable articles, such as breast implants. When used in vivo, the compositions are useful for inhibiting post-surgical spinal and other tissue adhesions, for filling tissue divots, tissue tracts, body cavities, surgical defects, and the like.

WO/2011/013791	KIDNEY-TARGETING DRUG DELIVERY AGENT COMPRISING GENETICALLY MODIFIED GELATIN
JP2010501039	Dendrimer and its manufacture and usage
JP2017079776	SINGLE-STRANDED RNAi AGENTS CONTAINING AN INTERNAL NON-NUCLEIC ACID SPACER

Donald G. Wallace
Curry Jay. Leach
Narinder S. Shargill
Felix Vega
A. Edward Osawa

JP2009187571A

December 21, 2011

August 12, 2009

Click for automatic bibliography generation  

BAXTER INTERNATIONAL INCORP0RATED
BAXTER HEALTHCARE S.A.

A61K47/42; A01K1/015; A61F2/00; A61K9/00; A61K38/43; A61L24/00; A61L27/00; A61L27/52; A61L27/54; A61L31/00; A61L31/14; A61L31/16; A61M5/00; A61P7/04; A61P17/02; A61P41/00; C08J3/075; C08L1/00; C08L3/00; C08L5/00; C08L89/00; C08L101/00; C08L101/16; A61L

WO1994027630A1

Hidesaku Yamamoto
Takaaki Yasumura
Natsuki Morishita

Previous Patent: JPS4843078

Next Patent: JPS4843080